Insiders trading at IRIDEX
Over the last 21 years, insiders at IRIDEX have traded over $1,952,092 worth of IRIDEX stock and bought 1,330,571 units worth $7,196,100 . The most active insiders traders include Joshua Makower, James B Hawkins und Capital Fund, Lp Acuta. On average, IRIDEX executives and independent directors trade stock every 32 days with the average trade being worth of $18,723. The most recent stock trade was executed by Nandini Devi on 20 May 2022, trading 2,000 units of IRIX stock currently worth $6,200.
What does IRIDEX do?
iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.
What does IRIDEX's logo look like?
IRIDEX executives and stock owners
IRIDEX executives and other stock owners filed with the SEC include:
-
David Bruce,
President, Chief Executive Officer, Director -
Fuad Ahmad,
Interim Chief Financial Officer -
Patrick Mercer,
Chief Operating Officer -
David I. Bruce,
Pres, CEO & Director -
Patrick Mercer,
Chief Operating Officer -
Fuad Ahmad,
Interim Chief Financial Officer -
Doris Engibous,
Independent Director -
Lynn Lewis,
IR Contact Officer -
Robert Gunst,
Independent Chairman of the Board -
Scott Shuda,
Independent Director -
Kenneth Ludlum,
Independent Director -
Robert Grove,
Independent Director -
Leigh Salvo,
Head of Investor Relations -
George R Marcellino,
Director -
Capital Partners, L.P.Blue ...,
-
Ruediger Naumann Etienne,
Director -
Romeo R Dizon,
-
Sanford Fitch,
Director -
Atabak Mokari,
CFO and VP Corp Development -
Ronald Steckel,
VP, Operations -
Capital Partners, L.P.Blue ...,
-
Associates & Paragon Associ...,
-
William M Moore,
Director -
James H Mackaness,
Chief Financial Officer -
Barry G Caldwell,
President and CEO -
Larry Tannenbaum,
Chief Financial Officer -
James L Donovan,
VP, Corporate Business Develp. -
Beverly A Huss,
Director -
Ann D Rhoads,
Director -
Maria Sainz,
Director -
Ken Ludlum,
Director -
Capital Fund, Lp Acuta,
10% owner -
John M Nehra,
Director -
Joshua Makower,
Director -
Nandini Devi,
Director -
Capital Partners, L.P.Blue ...,
-
Catalyst Fund Ix, L.P.Blue ...,
-
Catalyst Fund Ix, L.P.Blue ...,
-
James B Hawkins,
Director -
Garrett A Garrettson,
Director -
Catalyst Fund Ix, L.P.Blue ...,
-
Eduardo Arias,
Sr. VP, Int'l Sales & Bus... -
Robert K Anderson,
Director -
Partners, L.L.C.Blue Line P...,
-
Dominik Beck,
President and CEO -
Partners, L.L.C.Blue Line C...,
-
Donald J Todd,
VP Marketing -
Capital Partners Ii, L.P.Bl...,
-
Partners, L.L.C.Blue Line C...,
-
Theodore A Boutacoff,
President and CEO -
Timothy S Powers,
Vice President, Operations -
Partners, L.L.C.Blue Line C...,
-
Partners, L.L.C.Blue Line P...,
-
Donald L Hammond,
Director -
Partners, L.L.C.Blue Line C...,
-
Partners, L.L.C.Blue Line C...,